Page last updated: 2024-08-21

plumbagin and Leukemia, Myeloid, Acute

plumbagin has been researched along with Leukemia, Myeloid, Acute in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, D; Li, K; Li, Y; Lin, R; Wang, Q; Yang, K; Zheng, L1
Han, X; Kong, X; Li, Z; Liu, L; Lu, Y; Luo, J; Pan, Z; Xie, Y; Xu, T; Zhao, L; Zhou, Y1
Berdel, WE; Dukare, S; Klempnauer, KH; Müller-Tidow, C; Piontek, T; Schlenke, P; Schmidt, TJ; Schomburg, C; Uttarkar, S1

Other Studies

3 other study(ies) available for plumbagin and Leukemia, Myeloid, Acute

ArticleYear
Anti-acute myeloid leukemia activity of 2-chloro-3-alkyl-1,4-naphthoquinone derivatives through inducing mtDNA damage and GSH depletion.
    Bioorganic & medicinal chemistry, 2018, 08-07, Volume: 26, Issue:14

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; DNA Damage; DNA, Mitochondrial; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Glutathione; Humans; Leukemia, Myeloid, Acute; Membrane Potential, Mitochondrial; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured

2018
Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Oncology reports, 2017, Volume: 37, Issue:6

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Leukemic; Glutathione; Humans; Leukemia, Myeloid, Acute; Mice; Mitochondria; Naphthoquinones; Reactive Oxygen Species; Recombinant Proteins; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays

2017
Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:12

    Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; E1A-Associated p300 Protein; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Naphthoquinones; Protein Binding; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-myb; Reactive Oxygen Species

2016